;

Articles Not Curated-Drug Studies-in vitro
Total hit(s): 73
S.No.
1
33713730
Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors
Antiviral Res
2021 May
4.12
2
33825201
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro
Br J Pharmacol
2021 Apr 6
6.48
3
33917313
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
Pharmaceuticals (Basel)
2021 Apr 6
4
33910954
Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity
J Virol
2021 Apr 28
4.16
5
33932547
Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro
Microb Pathog
2021 Apr 28
2.64
6
33903110
Overcoming culture restriction for SARS-CoV-2 in human cells facilitates the screening of compounds inhibiting viral replication
Antimicrob Agents Chemother
2021 Apr 26
4.68
7
33907750
Multidose evaluation of 6,710 drug repurposing library identifies potent SARS-CoV-2 infection inhibitors In Vitro and In Vivo
bioRxiv
2021 Apr 22
Its not a journal
8
33880524
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
J Antimicrob Chemother
2021 Apr 21
4.94
9
33821265
Discovery and in-vitro evaluation of potent SARS-CoV-2 entry inhibitors
bioRxiv
2021 Apr 2
Its not a journal
10
33919584
Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro
Biomedicines
2021 Apr 18
11
33686143
The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication
Sci Rep
2021 Mar 8
4.12
12
33688653
Blockade of SARS-CoV-2 infection in vitro by highly potent PI3K-α/mTOR/BRD4 inhibitor
bioRxiv
2021 Mar 5
Its not a journal
13
33806331
Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches
Pharmaceuticals (Basel)
2021 Mar 4
14
33862474
Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay
Bioorg Chem
2021 Mar 29
3.94
15
33791693
Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2
bioRxiv
2021 Mar 24
Its not a journal
16
33759449
Drugs in COVID-19 Clinical Trials: Predicting Transporter-Mediated Drug-Drug Interactions Using In Vitro Assays and Real-World Data
Clin Pharmacol Ther
2021 Mar 24
5.26
17
33778258
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms
ACS Omega
2021 Mar 23
2.55
18
33732940
Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro
Heliyon
2021 Mar
1.65
19
33558299
AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19
Antimicrob Agents Chemother
2021 Feb 8
4.68
1
20
33558781
Toward the understanding of national culture in the success of non-pharmaceutical technological interventions in mitigating COVID-19 pandemic
Ann Oper Res
2021 Feb 3
1
21
33637768
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection
Sci Data
2021 Feb 26
6.46
1
22
33622090
Remdesivir for the Treatment of COVID-19: A Need for Combined In Vivo and In Vitro Studies to Evaluate the Efficacy
J Pharm Pract
2021 Feb 24
1
23
33568500
Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors
Proc Natl Acad Sci U S A
2021 Feb 23
9.35
1
24
33538596
Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening
J Chem Inf Model
2021 Feb 22
4.04
1
25
33619486
Probing the SAM Binding Site of SARS-CoV-2 nsp14 in vitro Using SAM Competitive Inhibitors Guides Developing Selective bi-substrate Inhibitors
bioRxiv
2021 Feb 19
Its not a journal
1